GeoVax CEO Highlights Biothreat Readiness as FIFA World Cup 2026 Approaches

As North America gears up to host the FIFA World Cup 2026, GeoVax Labs, Inc. (Nasdaq: GOVX) is drawing attention to the critical need for robust public health readiness and biodefense capabilities. The tournament, which is expected to attract approximately 6.5 million attendees across the United States, Canada, and Mexico—including more than 1.2 million international visitors to U.S. host cities—presents a significant operational challenge for health authorities.

David A. Dodd, Chairman and Chief Executive Officer of GeoVax, stated, ‘FIFA 2026 represents more than a sporting event. It is a large-scale operational challenge occurring in an era of persistent biological risk.’ He emphasized that when millions of people move across borders and densely populated urban environments over a compressed period, health security becomes an operational necessity.

The announcement comes amid growing concerns regarding infectious diseases such as mpox, Ebola, hantavirus, and measles. Recent outbreaks have highlighted vulnerabilities in global health systems, including the rapid depletion of vaccine supplies during the mpox outbreaks and the ongoing Bundibugyo Ebola outbreak in Central Africa, which currently lacks a broadly licensed vaccine.

GeoVax believes that several priorities warrant increased attention as the World Cup approaches: expanding domestic vaccine manufacturing capacity, diversifying critical medical countermeasure supply chains, enhancing disease surveillance and rapid-response capabilities, supporting adaptable vaccine platform technologies, strengthening public-private health security partnerships, and improving stockpile management and deployment logistics.

The company’s development portfolio includes GEO-MVA, an MVA-based poxvirus vaccine candidate aimed at protecting against mpox and smallpox. GeoVax is also advancing Gedeptin®, an immuno-oncology program, and preclinical vaccine candidates targeting hemorrhagic fever pathogens like Ebola and Marburg viruses.

Dodd concluded, ‘By investing in manufacturing capacity, disease surveillance, and biodefense capabilities today, we can help ensure that the world’s attention remains focused where it belongs—on the athletes, the competition, and the spirit of international cooperation.’

For more information about GeoVax and its initiatives, visit www.geovax.com.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is GeoVax CEO Highlights Biothreat Readiness as FIFA World Cup 2026 Approaches.

The post GeoVax CEO Highlights Biothreat Readiness as FIFA World Cup 2026 Approaches appeared first on citybuzz.